Researchers at McGill University have reported that lithium, a long-established treatment for bipolar disorder, suppressed ...
Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...
Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...
In a randomized trial, ART intensification by doubling the dolutegravir dosage in people with HIV stably suppressed on ...
In an important discovery, researchers from Florida Atlantic University's Charles E. Schmidt College of Medicine have identified a never-before-seen mechanism that enables the human immunodeficiency ...
In a groundbreaking discovery, researchers from Florida Atlantic University's Charles E. Schmidt College of Medicine have identified a never-before-seen mechanism that enables the human ...
Living with HIV comes with unique health challenges, but advances in treatment have transformed it into a manageable chronic ...
A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Regensburg has unveiled insights into how HIV-1, the virus responsible for ...
Share on Pinterest Sunleca (lenacapavir) has been shown to be 100% effective at preventing HIV in females. andreswd/Getty Images A new study found that the drug Sunleca (lenacapavir) has been shown to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results